Status:
COMPLETED
Evaluating the Impact of an Equity Focused Dashboard and Clinical Support
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Hypertension
Diabetes
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
In this project, the impact of providing a practice-level equity dashboard that displays ambulatory quality outcome metrics stratified by race and language to primary care providers at Massachusetts G...
Detailed Description
A clinical program will be implemented to utilize the equity dashboard in routine clinical practice augmented by clinical support to address current disparities in hypertension control among MGH prima...
Eligibility Criteria
Inclusion
- \<Provider Eligibility\>
- • Massachusetts General Hospital primary care physician
Exclusion
- • Practice leaders and equity steering committee members as they will all get access to the equity dashboard data.
- \<Patient Eligibility\>
- Inclusion Criteria:
- • Uncontrolled Hypertension AND Black, Indigenous and People of Color (BIPOC) patients or Limited English proficiency (LEP).
Key Trial Info
Start Date :
March 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
10766 Patients enrolled
Trial Details
Trial ID
NCT05278806
Start Date
March 24 2022
End Date
April 30 2023
Last Update
June 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114